4White T C. Increased mRNA Levels of EBG16, CDR, and MDRl correlate with increasea in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus[J]. Antimicrob Agents Chemother,1997,41:1482.
5Marichal P, Bossche H V, Odds F C, et al. Molecular biological characterization of an azole - resistant Candida glabrata isolate[J]. Antimicrob Agents Chemother,1997, 41:2229.
6Miyazaki H, Miyazaki Y, Geber A, et al. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata [ J]. Antimicrob Agenta Chemother, 1998,42:1695.
7Franz R, Kelly S L, Lamb D C, et al. Multiple molecular mechanisms contribute to a stepwise developmem of fluconazole redstance in clinical Candida albicans strains[J].Antimicrob Agents Chemother, 1998 , 42 : 3065.
8Asai K,Tsuchimori N,Okonogi K,et al. Formantion of azole- resistant Candida albicans by mutation of sterol 14 - demethylase P450.[J].Antimicrob Agents Chemother, 1999,43(5):1163.
9Sanglard D,Ischer F, Calabrese D, et al.The ATP binding camette transporter gene CgCDR1 from Candida glabrata Is involved in the resistance of clinical isolates to azole antifungal agents[J]. Antimicrob Agents Chemother , 1999,43:2753.
10Aoyama Y,Kudo M,Asai K,et al. Emergence of fluconazole-resistant sterol 14 - demethylase P450 (CYP51) in Candida albicans is a model demonsuming the divenfification mechanism of P450[J].Arch Biochem Biophys,2000,379:170.
